• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

eIF3a 通过 HuR 调控 mTOR 信号和翻译控制在细胞对 DNA 损伤的反应中的作用。

eIF3a regulation of mTOR signaling and translational control via HuR in cellular response to DNA damage.

机构信息

Department of Cell and Cancer Biology, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA.

Department of Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA.

出版信息

Oncogene. 2022 Apr;41(17):2431-2443. doi: 10.1038/s41388-022-02262-5. Epub 2022 Mar 12.

DOI:10.1038/s41388-022-02262-5
PMID:35279705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9035104/
Abstract

eIF3a (eukaryotic translation initiation factor 3a), a subunit of the eIF3 complex, has been suggested to play a regulatory role in protein synthesis and in cellular response to DNA-damaging treatments. S6K1 is an effector and a mediator of mTOR complex 1 (mTORC1) in regulating protein synthesis and integrating diverse signals into control of cell growth and response to stress. Here, we show that eIF3a regulates S6K1 activity by inhibiting mTORC1 kinase via regulating Raptor synthesis. The regulation of Raptor synthesis is via eIF3a interaction with HuR (human antigen R) and binding of the eIF3a-HuR complex to the 5'-UTR of Raptor mRNA. Furthermore, mTORC1 may mediate eIF3a function in cellular response to cisplatin by regulating synthesis of NER proteins and NER activity. Taken together, we conclude that the mTOR signaling pathway may also be regulated by translational control and mediate eIF3a regulation of cancer cell response to cisplatin by regulating NER protein synthesis.

摘要

eIF3a(真核翻译起始因子 3a)是 eIF3 复合物的一个亚基,据推测它在蛋白质合成和细胞对 DNA 损伤处理的反应中发挥调节作用。S6K1 是 mTOR 复合物 1(mTORC1)的效应物和介导物,在调节蛋白质合成和整合多种信号以控制细胞生长和对压力的反应中起作用。在这里,我们表明 eIF3a 通过调节 Raptor 合成来抑制 mTORC1 激酶,从而调节 S6K1 活性。Raptor 合成的调节是通过 eIF3a 与 HuR(人类抗原 R)相互作用以及 eIF3a-HuR 复合物与 Raptor mRNA 5'-UTR 的结合实现的。此外,mTORC1 可能通过调节 NER 蛋白的合成和 NER 活性来介导 eIF3a 在细胞对顺铂反应中的功能。总之,我们得出结论,mTOR 信号通路也可能受到翻译调控的调节,并通过调节 NER 蛋白合成来介导 eIF3a 对顺铂的癌细胞反应的调节。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8520/9035104/63649dc80e64/nihms-1783728-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8520/9035104/59dc6da10c11/nihms-1783728-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8520/9035104/44cccc7b4dc0/nihms-1783728-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8520/9035104/0cfcfa7eeb4a/nihms-1783728-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8520/9035104/03dc02a28ef1/nihms-1783728-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8520/9035104/0760ea81ca89/nihms-1783728-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8520/9035104/b8f171c81dbd/nihms-1783728-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8520/9035104/3cb3d1593c7c/nihms-1783728-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8520/9035104/63649dc80e64/nihms-1783728-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8520/9035104/59dc6da10c11/nihms-1783728-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8520/9035104/44cccc7b4dc0/nihms-1783728-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8520/9035104/0cfcfa7eeb4a/nihms-1783728-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8520/9035104/03dc02a28ef1/nihms-1783728-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8520/9035104/0760ea81ca89/nihms-1783728-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8520/9035104/b8f171c81dbd/nihms-1783728-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8520/9035104/3cb3d1593c7c/nihms-1783728-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8520/9035104/63649dc80e64/nihms-1783728-f0008.jpg

相似文献

1
eIF3a regulation of mTOR signaling and translational control via HuR in cellular response to DNA damage.eIF3a 通过 HuR 调控 mTOR 信号和翻译控制在细胞对 DNA 损伤的反应中的作用。
Oncogene. 2022 Apr;41(17):2431-2443. doi: 10.1038/s41388-022-02262-5. Epub 2022 Mar 12.
2
Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma.eIF3a 在调节顺铂敏感性和鼻咽癌核苷酸切除修复的翻译控制中的作用。
Oncogene. 2011 Dec 1;30(48):4814-23. doi: 10.1038/onc.2011.189. Epub 2011 May 30.
3
Translational regulation of Chk1 expression by eIF3a via interaction with the RNA-binding protein HuR.eIF3a通过与RNA结合蛋白HuR相互作用对Chk1表达进行翻译调控。
Biochem J. 2020 May 29;477(10):1939-1950. doi: 10.1042/BCJ20200025.
4
N-myc downstream regulated 1 (NDRG1) is regulated by eukaryotic initiation factor 3a (eIF3a) during cellular stress caused by iron depletion.N- Myc 下游调节因子 1(NDRG1)在铁耗竭引起的细胞应激过程中受真核起始因子 3a(eIF3a)的调节。
PLoS One. 2013;8(2):e57273. doi: 10.1371/journal.pone.0057273. Epub 2013 Feb 21.
5
eIF3a improve cisplatin sensitivity in ovarian cancer by regulating XPC and p27Kip1 translation.真核生物翻译起始因子3a通过调节XPC和p27Kip1的翻译来提高卵巢癌对顺铂的敏感性。
Oncotarget. 2015 Sep 22;6(28):25441-51. doi: 10.18632/oncotarget.4555.
6
Translational regulation of RPA2 via internal ribosomal entry site and by eIF3a.通过内部核糖体进入位点和 eIF3a 对 RPA2 的翻译调控。
Carcinogenesis. 2013 Jun;34(6):1224-31. doi: 10.1093/carcin/bgt052. Epub 2013 Feb 7.
7
The translation regulatory subunit eIF3f controls the kinase-dependent mTOR signaling required for muscle differentiation and hypertrophy in mouse.翻译调节亚基 eIF3f 控制着肌肉分化和肥大所必需的激酶依赖性 mTOR 信号通路。
PLoS One. 2010 Feb 1;5(2):e8994. doi: 10.1371/journal.pone.0008994.
8
Control of Paip1-eukayrotic translation initiation factor 3 interaction by amino acids through S6 kinase.通过 S6 激酶控制 Paip1-真核翻译起始因子 3 的相互作用。
Mol Cell Biol. 2014 Mar;34(6):1046-53. doi: 10.1128/MCB.01079-13. Epub 2014 Jan 6.
9
Translation initiation factor eIF3a regulates glucose metabolism and cell proliferation via promoting small GTPase Rheb synthesis and AMPK activation.翻译起始因子 eIF3a 通过促进小 GTP 酶 Rheb 的合成和 AMPK 的激活来调节葡萄糖代谢和细胞增殖。
J Biol Chem. 2022 Jul;298(7):102044. doi: 10.1016/j.jbc.2022.102044. Epub 2022 May 18.
10
RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells.RhoA 调节哺乳动物细胞中雷帕霉素靶蛋白复合物 1(mTORC1)的信号转导。
Cell Signal. 2014 Mar;26(3):461-7. doi: 10.1016/j.cellsig.2013.11.035. Epub 2013 Dec 3.

引用本文的文献

1
Metformin suppresses the mitochondrial and transcriptional response to exercise, revealing a conserved BCL6B-associated angiogenic program.二甲双胍抑制对运动的线粒体和转录反应,揭示了一个保守的与BCL6B相关的血管生成程序。
J Appl Physiol (1985). 2025 Aug 1;139(2):541-556. doi: 10.1152/japplphysiol.00432.2025. Epub 2025 Jul 22.
2
Ferroptosis and protein translation: emerging perspectives in the research of myocardial infraction.铁死亡与蛋白质翻译:心肌梗死研究中的新观点
Front Cardiovasc Med. 2025 May 2;12:1592333. doi: 10.3389/fcvm.2025.1592333. eCollection 2025.
3
eIF3a function in immunity and protection against severe sepsis by regulating B cell quantity and function through mA modification.

本文引用的文献

1
The effect of eIF3a on anthracycline-based chemotherapy resistance by regulating DSB DNA repair.eIF3a 通过调节 DSB DNA 修复对蒽环类化疗耐药的影响。
Biochem Pharmacol. 2021 Aug;190:114616. doi: 10.1016/j.bcp.2021.114616. Epub 2021 May 20.
2
Synthesis and Identification of a Novel Lead Targeting Survivin Dimerization for Proteasome-Dependent Degradation.新型靶向存活素二聚化促进蛋白酶体依赖降解的先导化合物的合成与鉴定。
J Med Chem. 2020 Jul 9;63(13):7243-7251. doi: 10.1021/acs.jmedchem.0c00475. Epub 2020 Jun 9.
3
Translational regulation of Chk1 expression by eIF3a via interaction with the RNA-binding protein HuR.
真核生物翻译起始因子3a(eIF3a)通过N6-甲基腺苷(m6A)修饰调节B细胞数量和功能,从而在免疫及抵御严重脓毒症中发挥作用。
Acta Pharm Sin B. 2025 Mar;15(3):1571-1588. doi: 10.1016/j.apsb.2025.02.005. Epub 2025 Feb 11.
4
ROBO1 enhanced esophageal carcinoma cell radioresistance through accelerating G3BP2-mediated eIF3A degradation.ROBO1通过加速G3BP2介导的eIF3A降解增强食管癌细胞的放射抗性。
Cell Death Dis. 2025 Apr 6;16(1):256. doi: 10.1038/s41419-025-07604-1.
5
The eIF3a translational control axis in the Wnt/β-catenin signaling pathway and colon tumorigenesis.Wnt/β-连环蛋白信号通路中 eIF3a 的翻译控制轴与结肠肿瘤发生。
Cancer Lett. 2024 Nov 28;605:217303. doi: 10.1016/j.canlet.2024.217303. Epub 2024 Oct 15.
6
Deciphering EIF3D's Role in Immune Regulation and Malignant Progression: A Pan-Cancer Analysis with a Focus on Colon Adenocarcinoma.解读真核翻译起始因子3D(EIF3D)在免疫调节和恶性进展中的作用:一项以结肠腺癌为重点的泛癌分析
J Inflamm Res. 2024 Sep 30;17:6847-6862. doi: 10.2147/JIR.S469948. eCollection 2024.
7
Analysis of m6A regulators related immune characteristics in ankylosing spondylitis by integrated bioinformatics and computational strategies.整合生物信息学和计算策略分析强直性脊柱炎中 m6A 调节因子相关免疫特征。
Sci Rep. 2024 Feb 1;14(1):2724. doi: 10.1038/s41598-024-53184-z.
8
Theranostic imaging and multimodal photodynamic therapy and immunotherapy using the mTOR signaling pathway.基于 mTOR 信号通路的治疗性影像学与多模态光动力治疗和免疫治疗
Nat Commun. 2023 Sep 2;14(1):5350. doi: 10.1038/s41467-023-40826-5.
9
Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancer.核糖核苷酸还原酶M2(RRM2):人类癌症中的调控、功能及靶向策略
Genes Dis. 2022 Dec 28;11(1):218-233. doi: 10.1016/j.gendis.2022.11.022. eCollection 2024 Jan.
10
The Role of mTORC1 Pathway and Autophagy in Resistance to Platinum-Based Chemotherapeutics.mTORC1 通路和自噬在铂类化疗耐药中的作用。
Int J Mol Sci. 2023 Jun 26;24(13):10651. doi: 10.3390/ijms241310651.
eIF3a通过与RNA结合蛋白HuR相互作用对Chk1表达进行翻译调控。
Biochem J. 2020 May 29;477(10):1939-1950. doi: 10.1042/BCJ20200025.
4
eIF3a: A new anticancer drug target in the eIF family.真核起始因子 3a:eIF 家族中的一个新的抗癌药物靶点。
Cancer Lett. 2018 Jan 1;412:81-87. doi: 10.1016/j.canlet.2017.09.055. Epub 2017 Oct 12.
5
mTOR Signaling in Growth, Metabolism, and Disease.生长、代谢及疾病中的mTOR信号传导
Cell. 2017 Mar 9;168(6):960-976. doi: 10.1016/j.cell.2017.02.004.
6
Human eIF3b and eIF3a serve as the nucleation core for the assembly of eIF3 into two interconnected modules: the yeast-like core and the octamer.人类真核生物翻译起始因子3b(eIF3b)和真核生物翻译起始因子3a(eIF3a)作为真核生物翻译起始因子3(eIF3)组装成两个相互连接模块的成核核心:酵母样核心和八聚体。
Nucleic Acids Res. 2016 Dec 15;44(22):10772-10788. doi: 10.1093/nar/gkw972. Epub 2016 Oct 19.
7
Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors.新型PI3K-AKT-mTOR抑制剂可克服胰腺神经内分泌肿瘤长期获得性依维莫司耐药性。
Br J Cancer. 2016 Mar 15;114(6):650-8. doi: 10.1038/bjc.2016.25.
8
PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma.磷脂酰肌醇-3激酶/蛋白激酶B/哺乳动物雷帕霉素靶蛋白(PI3K/AKT/mTOR)抑制与阿霉素联合使用是治疗平滑肌肉瘤的有效疗法。
J Transl Med. 2016 Mar 8;14:67. doi: 10.1186/s12967-016-0814-z.
9
Structural insights of mTOR complex 1.雷帕霉素靶蛋白复合物1的结构见解
Cell Res. 2016 Mar;26(3):267-8. doi: 10.1038/cr.2016.10. Epub 2016 Jan 22.
10
Small-molecule inhibitors targeting the DNA-binding domain of STAT3 suppress tumor growth, metastasis and STAT3 target gene expression in vivo.靶向STAT3 DNA结合结构域的小分子抑制剂在体内可抑制肿瘤生长、转移及STAT3靶基因表达。
Oncogene. 2016 Feb 11;35(6):783-92. doi: 10.1038/onc.2015.215. Epub 2015 Jun 15.